- Home
- CSBR vs ZENV Comparison
CSBR vs ZENV Comparison
Compare CSBR & ZENV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSBR
- ZENV
- Stock Information
- Founded
- CSBR 1985
- ZENV 2005
- Country
- CSBR United States
- ZENV Brazil
- Employees
- CSBR N/A
- ZENV N/A
- Industry
- CSBR Biotechnology: Biological Products (No Diagnostic Substances)
- ZENV Computer Software: Prepackaged Software
- Sector
- CSBR Health Care
- ZENV Technology
- Exchange
- CSBR Nasdaq
- ZENV Nasdaq
- Market Cap
- CSBR 90.2M
- ZENV 79.7M
- IPO Year
- CSBR 1986
- ZENV 2021
- Fundamental
- Price
- CSBR $6.48
- ZENV $1.37
- Analyst Decision
- CSBR Strong Buy
- ZENV
- Analyst Count
- CSBR 1
- ZENV 0
- Target Price
- CSBR $12.00
- ZENV N/A
- AVG Volume (30 Days)
- CSBR 15.1K
- ZENV 53.6K
- Earning Date
- CSBR 09-15-2025
- ZENV 11-17-2025
- Dividend Yield
- CSBR N/A
- ZENV N/A
- EPS Growth
- CSBR N/A
- ZENV N/A
- EPS
- CSBR 0.21
- ZENV N/A
- Revenue
- CSBR $56,878,000.00
- ZENV $201,426,369.00
- Revenue This Year
- CSBR $7.31
- ZENV $6.49
- Revenue Next Year
- CSBR $12.01
- ZENV $3.82
- P/E Ratio
- CSBR $30.18
- ZENV N/A
- Revenue Growth
- CSBR 10.11
- ZENV 24.80
- 52 Week Low
- CSBR $3.75
- ZENV $1.02
- 52 Week High
- CSBR $11.99
- ZENV $3.03
- Technical
- Relative Strength Index (RSI)
- CSBR 47.59
- ZENV 46.60
- Support Level
- CSBR $6.29
- ZENV $1.34
- Resistance Level
- CSBR $6.79
- ZENV $1.45
- Average True Range (ATR)
- CSBR 0.25
- ZENV 0.06
- MACD
- CSBR 0.03
- ZENV 0.00
- Stochastic Oscillator
- CSBR 33.83
- ZENV 48.18
About CSBR Champions Oncology Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
About ZENV Zenvia Inc.
Zenvia Inc provides a platform that enables companies to create journeys for their end customers across a variety of channels. The company operates in two reportable segments namely CPaaS and SaaS. It has a geographic presence in Brazil, the USA, Argentina, Mexico, and Others. The company generates the majority of its revenue from Brazil.